Semalytix develops AI-based solutions that support pharmaceutical companies in becoming more customer-focused. Using cutting-edge automatic text comprehension technology, Semalytix' Pharos platform ingests and processes millions of forum and social media posts as well as CRM system records within seconds. Pharos captures real-world perceptions and experiences shared by health care practitioners and patients in real time. Insights from Pharos’ interactive living reports enable pharma companies to focus on the actual needs of their customers, and to understand what would really improve their conditions and their lives. Semalytix’s Pharos is an AI-based real world evidence generation tool that ingests data and breaks it down so you can receive specific information about the disease you’re investigating — zooming into specific target populations and studying nearly any variable you are interested in.
Total Funding: €4.3 M
Funding Stage: Series A
Business Stage: Scaling Up
Market: B2C, B2B
Company Size: 26 to 50
Founded: 2015
For AI Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI Startup founders or founders at Semalytix
Semalytix - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups
Semalytix - Manage Profile